Educational, research-use-only content. This article summarizes published scientific literature for informational purposes only and is not medical advice. The compounds discussed are supplied strictly for in-vitro laboratory research and are not approved for human or veterinary use.
What is SS-31?
SS-31, also known by its drug name elamipretide, is a small mitochondria-targeted peptide. It concentrates at the inner mitochondrial membrane (associating with cardiolipin) and is studied as a novel mitochondrial antioxidant (Zhao et al., 2019).
What the research examined
In a mouse model where lipopolysaccharide (LPS) induced mitochondrial dysfunction, oxidative stress, and memory impairment, treatment with elamipretide significantly reduced those effects — protecting against mitochondrial dysfunction and oxidative stress, supporting BDNF-related synaptic signaling, and improving learning and memory performance in behavioral tests (Zhao et al., 2019).
How it is thought to work
By targeting mitochondria and reducing oxidative damage, SS-31 is studied for its potential to preserve mitochondrial function in tissues with high energy demand — a focus of research into neurological and cardiac conditions (Zhao et al., 2019).
The limits of the current evidence
- The cited evidence is from animal models; elamipretide has been evaluated in clinical trials for specific conditions but is not an approved general-use medicine.
- This material is supplied for laboratory research use only.
References
According to PubMed:
- Zhao W, et al. Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by LPS in mice. J Neuroinflammation. 2019. doi:10.1186/s12974-019-1627-9
